eXoZymes, Inc.
eXoZymes, Inc. scores highest on Anchor (56) and lowest on Price (6). Its PosiPenta is 31.19 out of 100, weaker than most similar companies.
On the Penta Grid this week, eXoZymes, Inc. is Grid #742 of 837 in the Healthcare sector in United States, and Grid #3,546 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| eXoZymes, Inc. | 31.19 | 6 | 45 | 22 | 27 | 56 |
| Cryo-Cell International, Inc. | 64.20 | 0 | 76 | 90 | 95 | 60 |
| Lite Strategy, Inc. | 45.46 | 44 | 32 | 54 | 50 | 48 |
| CVRx, Inc. | 27.24 | 31 | 29 | 11 | 15 | 50 |
| EyePoint, Inc. | 29.52 | 33 | 30 | 12 | 34 | 39 |
| Precipio, Inc. | 51.56 | 24 | 73 | 61 | 56 | 44 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.44 |
| P/B ratio | 10.41 |
EEarnings
| Trailing EPS | ₹-112.71 |
| Forward EPS | — |
NNitro
| Price | 387.38 |
| 52-week high | 1742.76 |
| 52-week low | 350.92 |
| Fall from 52-week high | 77.8% |
TTorque
| Return on equity (ROE) | -187.16% |
| Debt-to-equity | 0.30 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹360 Cr |
| Insider holding | 65.35% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is eXoZymes, Inc.'s PosiPenta score?
eXoZymes, Inc.'s PosiPenta is 31.19 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does eXoZymes, Inc. stand on the Penta Grid?
On the Penta Grid this week, eXoZymes, Inc. is Grid #742 of 837 in the Healthcare sector in United States, and Grid #3,546 of 4,000 in United States.
Which PosiPenta pillar is strongest for eXoZymes, Inc.?
Anchor (stability and dividends), with a score of 56 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for eXoZymes, Inc.?
Price (valuation), with a score of 6 out of 100: much weaker than most similar companies.
Has eXoZymes, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.79 points, from 26.40 to 31.19.
PositoAI is for research and education only and is not investment advice.